126 related articles for article (PubMed ID: 32683105)
1. Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: Relation to hemodynamic parameters and the presence of Down syndrome.
Souza MFS; Carvalho ES; Maeda NY; Thomaz AM; Zorzanelli L; Castro CR; Pereira J; Lopes AA
Cytokine; 2020 Oct; 134():155192. PubMed ID: 32683105
[TBL] [Abstract][Full Text] [Related]
2. Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac Shunts.
Maeda NY; Aiello VD; Santos PC; Thomaz AM; Kajita LJ; Bydlowski SP; Lopes AA
Mediators Inflamm; 2019; 2019():7305028. PubMed ID: 30881226
[TBL] [Abstract][Full Text] [Related]
3. Relation of Cytokine Profile to Clinical and Hemodynamic Features in Young Patients With Congenital Heart Disease and Pulmonary Hypertension.
Zorzanelli L; Maeda N; Clavé M; Thomaz A; Galas F; Rabinovitch M; Lopes A
Am J Cardiol; 2017 Jan; 119(1):119-125. PubMed ID: 28247848
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Gürkan A; Eren G; Çetinkalp Ş; Akçay YD; Emingil G; Atilla G
Arch Oral Biol; 2016 Sep; 69():82-8. PubMed ID: 27270225
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome as a factor influencing hemodynamic response to pulmonary artery banding.
Borowski A; Zeuchner M; Schickendantz S; Korb H
Pediatr Cardiol; 1996; 17(6):375-81. PubMed ID: 8781087
[TBL] [Abstract][Full Text] [Related]
6. Serum Cytokines in Young Pediatric Patients with Congenital Cardiac Shunts and Altered Pulmonary Hemodynamics.
Zorzanelli L; Maeda NY; Clavé MM; Aiello VD; Rabinovitch M; Lopes AA
Mediators Inflamm; 2016; 2016():7672048. PubMed ID: 27656048
[No Abstract] [Full Text] [Related]
7. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury.
Zhou Y; Guo W; Zhu Z; Hu Y; Wang Y; Zhang X; Wang W; Du N; Song T; Yang K; Guan Z; Wang Y; Guo A
J Neuroinflammation; 2018 Sep; 15(1):253. PubMed ID: 30180853
[TBL] [Abstract][Full Text] [Related]
8. Circulating macrophage migration inhibitory factor (MIF) in patients with heart failure.
Luedike P; Alatzides G; Papathanasiou M; Heisler M; Pohl J; Lehmann N; Rassaf T
Cytokine; 2018 Oct; 110():104-109. PubMed ID: 29723777
[TBL] [Abstract][Full Text] [Related]
9. The pulmonary vascular bed in children with Down syndrome.
Chi TPL?Krovetz J
J Pediatr; 1975 Apr; 86(4):533-8. PubMed ID: 123955
[TBL] [Abstract][Full Text] [Related]
10. No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts.
Brun H; Ueland T; Thaulow E; Damas JK; Yndestad A; Aukrust P; Holmstrøm H
Congenit Heart Dis; 2011; 6(4):338-46. PubMed ID: 21450032
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis.
Wang Q; Han W; Niu J; Sun B; Dong W; Li G
Respir Res; 2019 Mar; 20(1):50. PubMed ID: 30841876
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic study of pulmonary vascular resistances in subjects with Down's syndrome with atrioventricular canal].
Agnetti A; Carano N; Haitink O; Balestrazzi P; Squarcia U; Giovannelli G
Pediatr Med Chir; 1981; 3(6):463-6. PubMed ID: 6211660
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome.
Yamaki S; Horiuchi T; Sekino Y
Am J Cardiol; 1983 May; 51(9):1502-6. PubMed ID: 6221650
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.
Merchant S; Nadaraj S; Chowdhury D; Parnell VA; Sison C; Miller EJ; Ojamaa K
Mol Med; 2008; 14(3-4):124-30. PubMed ID: 18079996
[TBL] [Abstract][Full Text] [Related]
15. Respiratory viruses and postoperative hemodynamics in patients with unrestrictive congenital cardiac communications: a prospective cohort study.
Abud KCO; Machado CM; Vilas Boas LS; Maeda NY; Carvalho ES; Souza MFS; Gaiolla PV; Castro CRP; Pereira J; Rabinovitch M; Lopes AA
Eur J Med Res; 2023 Jan; 28(1):38. PubMed ID: 36670454
[TBL] [Abstract][Full Text] [Related]
16. MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real life cohort.
Pohl J; Rammos C; Totzeck M; Stock P; Kelm M; Rassaf T; Luedike P
Resuscitation; 2016 Mar; 100():32-7. PubMed ID: 26784134
[TBL] [Abstract][Full Text] [Related]
17. Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF).
Luedike P; Alatzides G; Papathanasiou M; Heisler M; Pohl J; Lehmann N; Rassaf T
Eur J Med Res; 2018 May; 23(1):22. PubMed ID: 29728137
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of macrophage migration inhibitory factor in autism spectrum disorders.
Ning J; Xu L; Shen CQ; Zhang YY; Zhao Q
Neurotoxicology; 2019 Mar; 71():1-5. PubMed ID: 30503813
[TBL] [Abstract][Full Text] [Related]
19. Effect of low dosage inhaled nitric oxide on pulmonary hypertension in congenital heart disease.
Kazue T
Kurume Med J; 1995; 42(4):281-90. PubMed ID: 8667600
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response.
Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP
Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
